Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2015 Nov 7:15:141.
doi: 10.1186/s12890-015-0133-9.

Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study

Affiliations
Multicenter Study

Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study

Sandra Dury et al. BMC Pulm Med. .

Abstract

Background: Bronchiectasis is characterized by abnormal, permanent and irreversible dilatation of the bronchi, usually responsible for daily symptoms and frequent respiratory complications. Many causes have been identified, but only limited data are available concerning the association between bronchiectasis and renal transplantation.

Methods: We conducted a retrospective multicenter study of cases of bronchiectasis diagnosed after renal transplantation in 14 renal transplantation departments (French SPIESSER group). Demographic, clinical, laboratory and CT scan data were collected.

Results: Forty-six patients were included (mean age 58.2 years, 52.2 % men). Autosomal dominant polycystic kidney disease (32.6 %) was the main underlying renal disease. Chronic cough and sputum (50.0 %) were the major symptoms leading to chest CT scan. Mean duration of symptoms before diagnosis was 1.5 years [0-12.1 years]. Microorganisms were identified in 22 patients, predominantly Haemophilus influenzae. Hypogammaglobulinemia was observed in 46.9 % patients. Bronchiectasis was usually extensive (84.8 %). The total bronchiectasis score was 7.4 ± 5.5 with a significant gradient from apex to bases. Many patients remained symptomatic (43.5 %) and/or presented recurrent respiratory tract infections (37.0 %) during follow-up. Six deaths (13 %) occurred during follow-up, but none were attributable to bronchiectasis.

Conclusions: These results highlight that the diagnosis of bronchiectasis should be considered in patients with de novo respiratory symptoms after renal transplantation. Further studies are needed to more clearly understand the mechanisms underlying bronchiectasis in this setting.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flowchart of patient selection for the study

References

    1. Barry JM. Immunosuppressive drugs in renal transplantation. A review of the regimens. Drugs. 1992;44:554–6. doi: 10.2165/00003495-199244040-00003. - DOI - PubMed
    1. Reid L. Reduction in bronchial subdivision in bronchiectasis. Thorax. 1950;5:233–47. doi: 10.1136/thx.5.3.233. - DOI - PMC - PubMed
    1. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246:697–722. doi: 10.1148/radiol.2462070712. - DOI - PubMed
    1. O’Donnell AE. Bronchiectasis. Chest. 2008;134:815–23. doi: 10.1378/chest.08-0776. - DOI - PubMed
    1. Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2007;176:1215–21. doi: 10.1164/rccm.200703-489OC. - DOI - PubMed

Publication types

MeSH terms